|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
| Bladder Cancer |
|
Free Subscription
1 Am J Cancer Res |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Bladder Cancer is free of charge.
Mineralocorticoid receptor signaling inhibits bladder cancer progression.
Am J Cancer Res. 2024;14:696-708.
PubMed
Abstract available
Paradigm Shifting Research: Key Studies in Urologic Oncology.
Ann Surg Oncol. 2024;31:2529-2537.
PubMed
Abstract available
Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in
Patients with Upper Tract Urothelial Carcinoma.
Ann Surg Oncol. 2024;31:2538-2544.
PubMed
Abstract available
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and
Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After
Platinum-based Chemotherapy.
Anticancer Res. 2024;44:1271-1279.
PubMed
Abstract available
Appl Immunohistochem Mol Morphol
Diminution of Primary Cilia in the Stromal Cells at the Tumor-stromal Interface
Correlates With an Aggressive Tumor Biology in the Urothelial Carcinoma of the
Urinary Bladder.
Appl Immunohistochem Mol Morphol. 2024;32:130-136.
PubMed
Abstract available
The relationship between income, health insurance, and employment status as
prognostic indicators of bladder cancer: a survival analysis.
Arch Ital Urol Androl. 2024 Mar 7:12305. doi: 10.4081/aiua.2024.12305.
PubMed
Abstract available
Biochim Biophys Acta Mol Basis Dis
Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and
enhances immunotherapeutic sensitivity.
Biochim Biophys Acta Mol Basis Dis. 2024 Feb 28:167106.
PubMed
Abstract available
Establishment of bladder cancer spheroids and cultured in microfluidic platform
for predicting drug response.
Bioeng Transl Med. 2023;9:e10624.
PubMed
Abstract available
Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer
therapy.
Biomaterials. 2024;307:122514.
PubMed
Abstract available
A Bayesian Bernoulli-Exponential joint model for binary longitudinal outcomes and
informative time with applications to bladder cancer recurrence data.
BMC Med Res Methodol. 2024;24:54.
PubMed
Abstract available
Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial
bladder carcinoma through the COX-2/PGE2/IDO1 Axis.
Br J Cancer. 2024;130:880-891.
PubMed
Abstract available
Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in
patients with neoplastic urinary bladder diverticula: A major cancer center
experience.
Cancer Cytopathol. 2024;132:144-151.
PubMed
Abstract available
Urine cytology in the detection of renal cell carcinomas - a territory-wide
multi-institutional retrospective review of more than 2 decades.
Cancer Cytopathol. 2024;132:186-192.
PubMed
Abstract available
Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract
Urothelial Carcinoma.
Cancer Genomics Proteomics. 2024;21:137-143.
PubMed
Abstract available
Integrating molecular subtype and CD8(+) T cells infiltration to predict
treatment response and survival in muscle-invasive bladder cancer.
Cancer Immunol Immunother. 2024;73:66.
PubMed
Abstract available
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and
Response to Immune Checkpoint Blockade in Cancer.
Cancer Immunol Res. 2024;12:287-295.
PubMed
Abstract available
Secondary bladder and colorectal cancer after treatments for prostate cancer: A
population based study.
Cancer Med. 2024;13:e6922.
PubMed
Abstract available
POLQ identifies a better response subset to immunotherapy in muscle-invasive
bladder cancer with high PD-L1.
Cancer Med. 2024;13:e6962.
PubMed
Abstract available
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in
Urothelial Carcinoma.
Cancer Res. 2024;84:725-740.
PubMed
Abstract available
Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of
Non-Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024;22:102048.
PubMed
Abstract available
Development of a prognostic model for muscle-invasive bladder cancer using
glutamine metabolism.
Comput Biol Med. 2024;171:108223.
PubMed
Abstract available
A comparison between conventional and the Paris systems of reporting urinary
cytopathology with a literature update.
Diagn Cytopathol. 2024;52:187-199.
PubMed
Abstract available
LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p/TNFSF10
axis.
Discov Oncol. 2024;15:65.
PubMed
Abstract available
Enferm Infecc Microbiol Clin (Engl Ed)
BCGitis with aortoiliac aneurysm involvement: Report of two cases and review of
the literature.
Enferm Infecc Microbiol Clin (Engl Ed). 2024;42:152-157.
PubMed
Abstract available
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends,
collaborations, and future avenues.
Front Immunol. 2024;15:1297542.
PubMed
Abstract available
Plain language summary of erdafitinib in locally advanced or metastatic
urothelial carcinoma: a phase 2 study with long-term follow-up.
Future Oncol. 2024;20:231-243.
PubMed
Abstract available
Bioinformatics analysis and experimental validation reveal that CDC20
overexpression promotes bladder cancer progression and potential underlying
mechanisms.
Genes Genomics. 2024 Mar 4. doi: 10.1007/s13258-024-01505.
PubMed
Abstract available
[Bladder Cancer Detected Incidentally by Cystoscopy before Radical
Prostatectomy].
Hinyokika Kiyo. 2024;70:39-43.
PubMed
Abstract available
Metastatic small cell bladder cancer treated with sequential systemic therapy
including pembrolizumab and amrubicin: A case report.
IJU Case Rep. 2023;7:127-130.
PubMed
Abstract available
Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the
COX-2/PGE2/JAK2/STAT3/MMP pathway.
Int J Radiat Biol. 2024 Mar 5:1-11. doi: 10.1080/09553002.2024.2324475.
PubMed
Abstract available
Causal association of smoking, blood lipids, and bladder cancer: Insights from a
multivariable and mediation mendelian randomization investigation.
J Cancer. 2024;15:1929-1939.
PubMed
Abstract available
Construction of endothelial cell signatures for predicting the diagnosis,
prognosis and immunotherapy response of bladder cancer via machine learning.
J Cell Mol Med. 2024;28:e18155.
PubMed
Abstract available
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder
cancer: tips and tricks for better efficacy and tolerability.
J Chemother. 2024 Mar 4:1-4. doi: 10.1080/1120009X.2024.2325765.
PubMed
The potential mechanism of ursolic acid in the treatment of bladder cancer based
on network pharmacology and molecular docking.
J Int Med Res. 2024;52:3000605241234006.
PubMed
Abstract available
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune
Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
JAMA Netw Open. 2024;7:e241215.
PubMed
Abstract available
The role of microbiota in tumorigenesis, progression and treatment of bladder
cancer.
Microbiome Res Rep. 2023;3:5.
PubMed
Abstract available
Oncologic surveillance intensity after endoscopic treatment of upper tract
urothelial carcinoma.
Minerva Urol Nephrol. 2024;76:88-96.
PubMed
Abstract available
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway
through RAB27B.
Mol Carcinog. 2024 Mar 5. doi: 10.1002/mc.23712.
PubMed
Abstract available
Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer.
N Engl J Med. 2024;390:944-946.
PubMed
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med. 2024;390:875-888.
PubMed
Abstract available
An Atlas of Dietary Intakes and Medication Uses on Risk of Bladder Cancer: A
Wide-Angle Mendelian Randomization Analysis.
Nutr Cancer. 2024 Mar 5:1-10. doi: 10.1080/01635581.2024.2324504.
PubMed
Abstract available
Landscape and Saturation Analysis of Mutations Associated With Race in Cancer
Genomes by Clinical Sequencing.
Oncologist. 2024;29:219-226.
PubMed
Abstract available
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced
or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.
Oncologist. 2024;29:244-253.
PubMed
Abstract available
Label-free screening of common urinary system tumors from blood plasma based on
surface-enhanced Raman spectroscopy.
Photodiagnosis Photodyn Ther. 2024;45:103900.
PubMed
Abstract available
Invited Commentary: VI-RADS and Routing Patient Care at the Muscularis Propria.
Radiographics. 2024;44:e230234.
PubMed
Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls.
Radiographics. 2024;44:e230149.
PubMed
Abstract available
Prospective evaluation of sexual health following radical cystectomy due to
bladder cancer.
Sex Med. 2024;12:qfae005.
PubMed
Abstract available
Discovery of anticancer function of Febrifugine: Inhibition of cell
proliferation, induction of apoptosis and suppression steroid synthesis in
bladder cancer cells.
Toxicol Appl Pharmacol. 2024;484:116878.
PubMed
Abstract available
The role of neoadjuvant chemotherapy for patients with variant histology muscle
invasive bladder cancer undergoing robotic cystectomy: Data from the
International Robotic Cystectomy Consortium.
Urol Oncol. 2024 Feb 29:S1078-1439(24)00002.
PubMed
Abstract available
Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic
Consequences.
Urology. 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
PubMed
A Randomized Clinical Trial Evaluating Indigo Carmine as a Visualization Aid for
Evaluating Ureteral Patency.
Urology. 2024;184:105-111.
PubMed
Abstract available
Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper
Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.
Urology. 2024;184:75-78.
PubMed
Abstract available
TM9SF1 is implicated in promoting the proliferation and invasion of bladder
cancer cells.
World J Clin Oncol. 2024;15:175-177.
PubMed
Abstract available
TM9SF1 promotes bladder cancer cell growth and infiltration.
World J Clin Oncol. 2024;15:302-316.
PubMed
Abstract available
A phase 2 pilot study of water irrigation after transurethral resection of
bladder tumor (WATIP) demonstrating safety, feasibility and activity.
World J Urol. 2024;42:115.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
